SCHEMBL7007986

SCHEMBL7007986

COc1cc(CCc2c(C)nc(N[C@@H](C)c3ccccc3)nc2N)cc(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 9/20 0.43
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
ALDH1A1 P00352 1/20 0.40
CYP19A1 P11511 1/20 0.39
PLK1 P53350 3/20 0.38
EGFR P00533 1/20 0.36
KRAS P01116 1/20 0.36
SOS1 Q07889 1/20 0.36
GRK6 P43250 1/20 0.36
AURKA O14965 1/20 0.36
RPS6KB1 P23443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7018081 0.90 ALDH1A1 (0.46) HTR7ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL7009364 0.83 HTR7 (0.49) HTR7ADRA1DADRA1AADRA1B
SCHEMBL4372273 0.83 TLR8 (0.46) HTR7ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL7014716 0.83 ALDH1A1 (0.41) HTR7ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL7007980 0.81 HTR7 (0.45) HTR7ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL7014065 0.81 HTR7 (0.47) HTR7ADRA1DADRA1AADRA1BPLK1
SCHEMBL7007978 0.81 HTR7 (0.45) HTR7ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL7006322 0.78 MAPK14 (0.44) HTR7ADRA1DADRA1AADRA1BPLK1
SCHEMBL7006329 0.76 F7 (0.44) HTR7ALDH1A1EGFR
SCHEMBL4383095 0.75 TLR7 (0.49) HTR7ADRA1DADRA1AADRA1BPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280781-A4 5-HT 7 RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2003-08-06 EP disclosed
EP-1280781-A1 5-HT 7 RECEPTOR ANTAGONISTS Bristol-Myers Squibb Company (US) 2003-02-05 EP disclosed
WO-2001085701-A1 5-HT7 RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-11-15 WO disclosed